TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Ohio Investigators

Steven E. Waggoner, MD

Ireland Cancer Center at University ...


Cleveland, Ohio - 44106 (216-844-5011)

Ireland Cancer Center at University ...


Cleveland, Ohio - 44106-5065 (216-844-4831)

Ireland Cancer Center at University ...


Cleveland, Ohio - 44106
  • CLINICAL TRIALS 22
  • CONDITIONS16
  • INTERVENTIONS43
  • SINCE2004
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer

February 2008 - December 2012
Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced Persistent or Recurrent Endometrial Cancer

September 2008 - October 2010
Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer

March 2005 - April 2008
BAY 43-9006 Plus Paclitaxel/Carboplatin in Women With GYN Tumors

August 2004 - August 2013
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB Recurrent or Persistent Cervical Cancer

April 2009 - December 2011
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II Stage III or Stage IV Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer

August 2009 - January 2016
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy Paclitaxel and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer

March 2009 - March 2013
Paclitaxel Carboplatin and Bevacizumab or Paclitaxel Carboplatin and Temsirolimus or Ixabepilone Carboplatin and Bevacizumab in Treating Patients With Stage III Stage IV or Recurrent Endometrial Cancer

October 2009 - July 2011
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage III or Stage IVA Endometrial Cancer

June 2009 - December 2013
Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery

February 2009 - February 2011
Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer

April 2010 - November 2011
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer

May 2006 - October 2008
Cisplatin and Paclitaxel in Treating Patients With Stage IIB Stage IIC Stage III or Stage IV Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cavity Cancer

February 2009 - August 2010
Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery

April 2010 - March 2014
Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer

March 2008 - March 2010
Second Curettage in Treating Patients With Persistent Non-Metastatic Gestational Trophoblastic Tumor

October 2007 - June 2010
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer

August 2009 - February 2015
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer

January 2010 - September 2013
Paclitaxel Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II Stage III or Stage IV Ovarian Epithelial Primary Peritoneal or Fallopian Tube Cancer

June 2004 - July 2005
Carboplatin Paclitaxel Bevacizumab and ABT-888 in Treating Patients With Newly Diagnosed Stage II Stage III or Stage IV Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer

October 2009 - July 2010
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma

November 2009 - January 2015
Paclitaxel and Carboplatin or Bleomycin Sulfate Etoposide Phosphate and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors

February 2010 - September 2020
Ovarian Neoplasms

Fatigue

Peritoneal Neoplasms

Fallopian Tube Neoplasms

Neurotoxicity Syndromes

Endometrial Neoplasms

Uterine Cervical Neoplasms

Sarcoma

Vulvar Neoplasms

Vaginal Neoplasms

Trophoblastic Neoplasms

Gestational Trophoblastic Neoplasms

Leiomyosarcoma

Hydatidiform Mole

Carcinosarcoma

Sex Cord-Gonadal Stromal Tumors

Placebo

Intensity-Modulated Radiation Therapy

Laboratory Biomarker Analysis

Questionnaire Administration

Quality-Of-Life Assessment

Filgrastim

Educational Intervention

Study Of Socioeconomic And Demographic Variables

Assessment Of Therapy Complications

Psychosocial Assessment And Care

Pharmacological Study

Paclitaxel

Carboplatin

Bevacizumab

Cisplatin

Docetaxel

Gemcitabine Hydrochloride

Adjuvant Therapy

Ifosfamide

Radiation Therapy

Veliparib

Temsirolimus

Bortezomib

Protein Expression Analysis

External Beam Radiation Therapy

Pegfilgrastim

Sorafenib Tosylate

Management Of Therapy Complications

Conventional Surgery

Tamoxifen Citrate

Etoposide Phosphate

Ixabepilone

Paclitaxel Albumin-Stabilized Nanoparticle Formulation

Topotecan Hydrochloride

Megestrol Acetate

Enzyme-Linked Immunosorbent Assay

Clinical Observation

Bleomycin Sulfate

Brachytherapy

Internet-Based Intervention

Paclitaxel Poliglumex

Communication Intervention

Levonorgestrel

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo